Peter Marks, Food and Drug Administration and Rfk Jr.
Digest more
Top News
Impacts
Forbes |
Marks was named CBER’s director in January 2016 and later played a role overseeing the first Trump administration’s “Operation Warp Speed,” a roughly $18 billion effort to ramp up development of a Cov...
Business Insider |
RBC Capital analyst Brian Abrahams warned that Marks’ exit could lead to disruptions at the FDA, affecting drug approvals and regulatory flexibility.
Read more on News Digest
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans
Former vaccine official Peter Marks said health secretary "wishes subservient confirmation of his misinformation and lies."
U.S. Sen. Bill Cassidy said Tuesday the abrupt resignation of the nation’s chief vaccines regulator did not violate his pact with health chief Robert F. Kennedy Jr., a